Therefore, it is speculated that IL-17A may damage endothelial cells and induce overexpression of TF in newly diagnosed APL patients, which initiates the coagulation cascade and promotes the formation of generalized microthrombus, leading to hemorrhage secondary to the massive consumption of coagulation factors. Here, IL17A is linked to acute promyelocytic leukemia.